Logo image of HMST

HOMESTREET INC (HMST) Stock Fundamental Analysis

NASDAQ:HMST - Nasdaq - US43785V1026 - Common Stock - Currency: USD

13.01  +0.21 (+1.64%)

After market: 13.01 0 (0%)

Fundamental Rating

2

HMST gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 396 industry peers in the Banks industry. HMST has a bad profitability rating. Also its financial health evaluation is rather negative. HMST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HMST has reported negative net income.
HMST had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HMST reported negative net income in multiple years.
In multiple years HMST reported negative operating cash flow during the last 5 years.
HMST Yearly Net Income VS EBIT VS OCF VS FCFHMST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

HMST has a Return On Assets of -1.81%. This is amonst the worse of the industry: HMST underperforms 97.73% of its industry peers.
HMST has a Return On Equity of -35.26%. This is amonst the worse of the industry: HMST underperforms 97.73% of its industry peers.
Industry RankSector Rank
ROA -1.81%
ROE -35.26%
ROIC N/A
ROA(3y)-0.45%
ROA(5y)0.27%
ROE(3y)-9.88%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A
HMST Yearly ROA, ROE, ROICHMST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

HMST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HMST Yearly Profit, Operating, Gross MarginsHMST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

1

2. Health

2.1 Basic Checks

HMST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HMST has been increased compared to 1 year ago.
The number of shares outstanding for HMST has been reduced compared to 5 years ago.
HMST has a worse debt/assets ratio than last year.
HMST Yearly Shares OutstandingHMST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
HMST Yearly Total Debt VS Total AssetsHMST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

HMST has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.41, HMST is doing worse than 76.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC14.92%
HMST Yearly LT Debt VS Equity VS FCFHMST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HMST Yearly Current Assets VS Current LiabilitesHMST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HMST have decreased strongly by -708.33% in the last year.
HMST shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.35%.
Measured over the past years, HMST shows a very negative growth in Revenue. The Revenue has been decreasing by -22.09% on average per year.
EPS 1Y (TTM)-708.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.28%
Revenue 1Y (TTM)-58.35%
Revenue growth 3Y-39.81%
Revenue growth 5Y-22.09%
Sales Q2Q%14.16%

3.2 Future

The Earnings Per Share is expected to grow by 69.14% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.59% on average over the next years. This is quite good.
EPS Next Y112.25%
EPS Next 2Y69.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year16.4%
Revenue Next 2Y12.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HMST Yearly Revenue VS EstimatesHMST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
HMST Yearly EPS VS EstimatesHMST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HMST. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 13.62, the valuation of HMST can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HMST indicates a slightly more expensive valuation: HMST is more expensive than 72.22% of the companies listed in the same industry.
HMST is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.25, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 13.62
HMST Price Earnings VS Forward Price EarningsHMST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HMST Per share dataHMST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

HMST's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HMST's earnings are expected to grow with 69.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.14%
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

HMST has a Yearly Dividend Yield of 6.44%, which is a nice return.
HMST's Dividend Yield is rather good when compared to the industry average which is at 3.46. HMST pays more dividend than 94.44% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, HMST pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.44%

5.2 History

HMST has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
HMST Yearly Dividends per shareHMST Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DP0%
EPS Next 2Y69.14%
EPS Next 3YN/A
HMST Yearly Income VS Free CF VS DividendHMST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

More info and screens

HOMESTREET INC

NASDAQ:HMST (6/6/2025, 8:00:01 PM)

After market: 13.01 0 (0%)

13.01

+0.21 (+1.64%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-28 2025-04-28/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners83.59%
Inst Owner Change0.49%
Ins Owners3.9%
Ins Owner Change1.79%
Market Cap246.15M
Analysts80
Price Target13.6 (4.53%)
Short Float %1.92%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield 6.44%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.16%
Min EPS beat(2)-120.58%
Max EPS beat(2)-35.75%
EPS beat(4)1
Avg EPS beat(4)-43.11%
Min EPS beat(4)-120.58%
Max EPS beat(4)13.27%
EPS beat(8)2
Avg EPS beat(8)-120.09%
EPS beat(12)3
Avg EPS beat(12)-86.35%
EPS beat(16)7
Avg EPS beat(16)-62.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.23%
Min Revenue beat(2)-4.6%
Max Revenue beat(2)-3.86%
Revenue beat(4)0
Avg Revenue beat(4)-4.69%
Min Revenue beat(4)-8.61%
Max Revenue beat(4)-1.68%
Revenue beat(8)0
Avg Revenue beat(8)-7.5%
Revenue beat(12)0
Avg Revenue beat(12)-7.03%
Revenue beat(16)0
Avg Revenue beat(16)-6.36%
PT rev (1m)-3.03%
PT rev (3m)7.74%
EPS NQ rev (1m)-42.1%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)-55.56%
EPS NY rev (3m)-55.56%
Revenue NQ rev (1m)-0.77%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.62
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 0.61
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)0.96
Fwd EY7.34%
FCF(TTM)-2.91
FCFYN/A
OCF(TTM)-3.2
OCFYN/A
SpS4.2
BVpS21.18
TBVpS15.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.81%
ROE -35.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.45%
ROA(5y)0.27%
ROE(3y)-9.88%
ROE(5y)-0.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.72%
Cap/Sales 6.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score1
WACC14.92%
ROIC/WACCN/A
Cap/Depr(3y)443.04%
Cap/Depr(5y)276.03%
Cap/Sales(3y)17.85%
Cap/Sales(5y)11.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-708.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.28%
EPS Next Y112.25%
EPS Next 2Y69.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-58.35%
Revenue growth 3Y-39.81%
Revenue growth 5Y-22.09%
Sales Q2Q%14.16%
Revenue Next Year16.4%
Revenue Next 2Y12.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-241.54%
OCF growth 3YN/A
OCF growth 5YN/A